<DOC>
	<DOCNO>NCT00634361</DOCNO>
	<brief_summary>This open-label trial omega-3 fatty acid symptom schizophrenia prodrome .</brief_summary>
	<brief_title>Ethyl-EPA Treatment Prodromal Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>meet criteria schizophrenia prodrome lifetime antipsychotic treatment</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>